Domain's Top Portfolio Company Stories 2015

A number of our portfolio companies made headlines this year. Here a just a few of those stories.

Therapeutics

Achillion Pharmaceuticals enters into worldwide collaboration for hepatitis C with Janssen. 

Esperion Therapeutics announces positive top-line phase 2b results for ETC-1002 added to stable statin therapy in patients with hypercholesterolemia. 

Meritage Pharma acquired by Shire. 

Syndax and Merck collaborate on immuno-oncology study.

Diagnostics

Astute Medical to launch its diagnostic in China thanks to $20M investment from FosunPharma. 

Sera Prognostics announces commercial access of its PreTRM test.  

Epic Sciences CSO, Dena Marrinucci, named to PharmaVOICE 100 and recognized as an honoree of MIT Technology Review's annual innovators under 35 list. 

Xagenic fuels platform expansion strategy with exclusive mutation detection technology acquisition. 

Medical Devices

Fractyl Laboratories named one of FierceMedicalDevices “Fierce 15” Med Tech Company of 2015.

Twelve acquired by Medtronic.